Varex Imaging Corporation reports fourth quarter revenue of $229 million and fiscal year 2025 revenue of $845 million

Reuters
2025/11/19
<a href="https://laohu8.com/S/VREX">Varex Imaging Corporation</a> reports fourth quarter revenue of $229 million and fiscal year 2025 revenue of $845 million

Varex Imaging Corporation reported fourth quarter fiscal year 2025 revenues of $229.0 million, an 11% increase year-over-year. Medical segment revenue was $152.0 million, up 5%, while Industrial segment revenue was $77.0 million, up 25%. For the full fiscal year 2025, revenues reached $845.0 million, a 4% increase over the prior year. The company reported a GAAP net loss of $1.70 per diluted share for the year, while non-GAAP net income was $0.90 per diluted share. Cash flow from operations totaled $42.0 million for fiscal 2025. Varex highlighted growth in global CT tube sales in the Medical segment and sustained momentum in its Industrial segment, including over $55.0 million in cargo systems orders and shipment of more than 15 new systems. The company also advanced photon counting technology for CT and launched a new radiographic detector from its facility in India.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Varex Imaging Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251118780346) on November 18, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10